雷普利金

最新新闻

• 评级变动
  Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $142 to $200
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  CCORF Maintains Repligen(RGEN.US) With Hold Rating, Cuts Target Price to $145
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 评级变动
  Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating, Announces Target Price $204
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Wells Fargo Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $185
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• 评级变动
  J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $165
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• Wells Fargo Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $185
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  William Blair Maintains Repligen(RGEN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  UBS Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $160
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• Barclays Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• 评级变动
  A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $175 to $200
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  Wolfe Research Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $145
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• Stifel Maintains Repligen(RGEN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• UBS Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  Benchmark Co. Upgrades Repligen(RGEN.US) to Buy Rating, Announces Target Price $185
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• 评级变动
  CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $145
  \u5e02\u573a\u8d44\u8baf · 2026/7/29

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。